Cosmo Technologies Ltd

Quick facts

Phase 3 pipeline

• Methylene Blue MMX® · Neurology
  Methylene Blue MMX is a modified-release formulation of methylene blue that acts as a mitochondrial function enhancer and antioxidant to improve cognitive and neurological outcomes.

Phase 2 pipeline

• Methylene Blue MMX tablets

Phase 1 pipeline

• CB-03-10
• Rifamycin SV-MMX® 600

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Cosmo Technologies Ltd portfolio CI brief
• Cosmo Technologies Ltd pipeline updates RSS